The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Randomized, placebo-controlled study of vinorelbine plus cisplatin with celecoxib and serum VEGF before treatment as a biomarker for patients with advanced non-small cell lung cancer.
Jun Pei
No relevant relationships to disclose
Tianqing Chu
No relevant relationships to disclose
Yuqing Lou
No relevant relationships to disclose
Chunlei Shi
No relevant relationships to disclose
Liwen Xiong
No relevant relationships to disclose
Aiqin Gu
No relevant relationships to disclose
Baohui Han
No relevant relationships to disclose